Get startedLog in
    Picture of Fennec Pharmaceuticals logo

    FENC — Fennec Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapHigh Flyer
    All News

    Brief: Fennec Pharmaceuticals Announces FDA Acceptance For Filing Of New Drug Application Resubmission For Pedmark

    Picture of Fennec Pharmaceuticals logoFennec Pharmaceuticals
    27/04/2022 11:11
    April 27 (Reuters) - Fennec Pharmaceuticals Inc  FENC.O :
    * FENNEC PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE FOR FILING OF NEW DRUG
APPLICATION RESUBMISSION FOR PEDMARK™
    * FENNEC PHARMACEUTICALS INC - PDUFA TARGET ACTION DATE FOR NDA IS SEPTEMBER
23,
2022

Source text for Eikon:  ID:nGNX7nR91P 
Further company coverage:  FENC.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Fennec Pharmaceuticals

    See all news